Skip to content

Sumika Chemical Analysis Service

Japanese comprehensive analysis company, established in 1972 as an independent spin-off of Sumitomo Chemical's analysis division, providing analytical and evaluation services across pharmaceuticals, environment, materials, and related fields.

Last updated September 16, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Sumika Chemical Analysis Service (SCAS) is a Japanese comprehensive analysis company. According to its corporate information, it was established in July 1972 in Konohana-ku, Osaka, having become independent from the analysis division of Sumitomo Chemical Co., Ltd. It describes itself as the largest-scale comprehensive analysis company in Japan, aiming to be a total solution company that applies scientifically grounded analysis and evaluation technologies. Its business areas include pharmaceuticals (supporting drug discovery research and CMC development), medical-related testing (newborn diseases and therapeutic drugs for medical institutions), environment (air, water, soil analysis), materials (semiconductors, materials, hazard evaluation), medical devices, wellness, sensory evaluation, regulatory science (pharmaceuticals, medical devices, cosmetics), and chemical registration applications. Its corporate philosophy, revised in 2012 on its 40th anniversary, is rooted in the "Sumitomo business spirit."

History

Sumika Chemical Analysis Service was established in July 1972 in Konohana-ku, Osaka, with capital of 2 million yen, having become independent from the analysis division of Sumitomo Chemical Co., Ltd. It subsequently expanded its network: opening the Oita office in July 1974 and the Niihama office in October 1974; the Chiba office in July 1976; increasing capital to 100 million yen in September 1986; opening the Tsukuba office in April 1989; renaming offices to business sites in February 1993, opening the Tokyo office in July 1993, and increasing capital to 200 million yen in October 1993; opening the Pharma business site in February 1995; increasing capital to 250 million yen in July 1997 and establishing SCAS SINGAPORE PTE LTD in November 1997; establishing the Biotechnology Center in July 2000; establishing the Pharmaceutical Business Headquarters in July 2004; opening the Nagoya office in April 2005 and establishing Enviro Solution Co., Ltd. in November 2005; establishing Sumika Chemical Analysis Technology (Shanghai) Co., Ltd. in May 2007 and SCAS Europe S.A./N.V. in Belgium in October 2007; establishing the Environment, Electronics, Industrial Support, Chemical Safety, and Pharmaceutical business divisions and the Technology Development Center in June 2008; reorganizing the Pharma business site into Pharma Osaka and Pharma Oita in July 2009; establishing SCAS-BTT Bioanalysis Co., Ltd. in May 2011 and opening the Hiroshima Sales Department in July 2011; establishing SCAS Korea, Ltd. in October 2012 and SCAS Taiwan, Ltd. in March 2013; opening the Utsunomiya Sales Department in April 2014 and establishing the Pharma Yodogawa business site in July 2014; reorganizing into three headquarters (Technology & Development, Client Service, Technical Solution) in June 2015 and renaming "business sites" to "laboratories"; reorganizing five business divisions into three (Pharmaceuticals, Materials, Health & Safety) in April 2018 and renaming the Technology & Development Headquarters to Management Promotion Headquarters; opening the Tokyo Office Shonan Office in October 2018; dissolving the SCAS-BTT Bioanalysis joint venture in October 2020; integrating the Yodogawa Laboratory into the Osaka and Oita Laboratories in August 2021; reorganizing headquarters organizations and abolishing the headquarters system in April and July 2022, reorganizing into three business divisions (Pharmaceuticals, Materials, Health & Safety) and consolidating the Hiroshima Sales Department into the Ehime and Fukuoka offices; integrating the Tsukuba Laboratory into the Chiba Laboratory in July 2023 with some functions continuing as the Tsukuba Satellite Laboratory; absorbing and merging subsidiary chromocenter Co., Ltd. in October 2023; opening the Tsukuba Satellite Laboratory within the National Institute of Advanced Industrial Science and Technology in November 2023; opening the Nakanoshima Office in April 2024; and registering Sumika Chemical Analysis Center Medical Lab Co., Ltd. (nickname: Yumesaki Lab) as a health testing laboratory in November 2025.

Products and positioning

Aiming to be a total solution company that solves diverse industrial challenges through scientifically grounded analysis and evaluation technologies; describes itself as Japan's largest-scale comprehensive analysis company.

Sources4 sources

Cite this profile: Cite the canonical profile. /brand-wiki/sumika-chemical-analysis-service · Editorial policy · How profiles are compiled